In the present study, we confirmed the high CYP1B1 immunoreactivity in 53 primary samples and 14 metastatic tissue samples from patients with malignant epithelial OC and only in a small portion of benign tumors, which was consistent with previous reports. Here, CYP1B1 is linked to benign neoplasm.